NCT04554550 is a clinical trial in Pelvic Organ Prolapse, sponsored by University of Pennsylvania.

Who is sponsoring NCT04554550?

NCT04554550 is sponsored by University of Pennsylvania.

What condition does NCT04554550 study?

NCT04554550 studies Pelvic Organ Prolapse.

Is NCT04554550 still recruiting?

NCT04554550 is currently completed. Last updated 25 July 2022.

Last reviewed 2022-07-25 · How we verify

NCT04554550

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Post-operative Cognitive Function Following Pelvic Floor Surgery

Completed Last updated 25 July 2022

What this trial tests

trial in Pelvic Organ Prolapse in 130 participants. Completed in 28 February 2022.

Timeline

13 August 2020

Primary endpoint
28 February 2022

28 February 2022

Quick facts

Lead sponsor	University of Pennsylvania
Status	Completed
Study type	OBSERVATIONAL
Enrollment	130
Start date	13 August 2020
Primary completion	28 February 2022
Estimated completion	28 February 2022
Sites	1 location across United States

Conditions studied

Pelvic Organ Prolapse — all drugs for Pelvic Organ Prolapse →

Sponsor

University of Pennsylvania

Who can join

60 and older, female only, with Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess cognitive function before and after surgery for pelvic organ prolapse using sensitive tests of various neurocognitive domains.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Cognitive function following surgery for pelvic organ prolapse.
Hassani D, Koelper N, Borodyanskaya Y, Arya NG, et al · · 2022 · cited 1× · PMID 36047412 · DOI 10.1002/nau.25035

Verify or expand the search:

Other recruiting trials for Pelvic Organ Prolapse

Currently open trials in the same condition.

NCT07471464 — Centered Surgery - Preoperative Counseling and Patient Satisfaction · recruiting
NCT07104292 — Pelvic Floor Muscle Training During Pregnancy · NA · recruiting
NCT07218016 — The AccelERate Trial · NA · recruiting
NCT07114029 — VNOTES Approach in Mesh Free Sacrocolpopexy: A Functional and Anatomic Evaluation · NA · recruiting
NCT07082023 — Comparison of V-NOTES and Laparoscopic Mesh-Free Sacrocolpopexy Techniques · NA · recruiting

Other University of Pennsylvania trials

Trials by the same sponsor.

NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04554550 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
Last refreshed: 25 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04554550.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing